TrialThe Journal of infectious diseases2023

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.

Judith S Currier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.